Gyon Technologies Capital Management, LP Natera, Inc. Transaction History

Gyon Technologies Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$34.17 - $47.91 $204,609 - $286,885	5,988 Added 43.45%	19,768 $794,000
Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $528,431 - $811,034	-14,309 Reduced 50.94%	13,780 $604,000
Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $69,987 - $110,815	2,488 Added 9.72%	28,089 $995,000
Q1 2022 May 12, 2022	BUY	$30.32 - $91.33 $776,222 - $2.34 Million	25,601 New	25,601 $1.04 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.